Clinical Trials · NCT02134977

Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"

Name: Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/AGonadorelin

Phase: N/A
Recruitment status: Completed
Sponsor: Takeda
Enrollment: 2,816
Start date: Sep 2011
Locations: See registry
Primary endpoint: Quality of Life Questionnaire for Cancer Patients Treated With Anticancer Drugs (QOL-ACD) Total and Subscale Score at Baseline

View Gonadorelin compound reference